FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to enantiomerically pure (2S)- or (2R)-N,N,N-trimethyl-2,3-bis[[(9Z)-1-oxo-9-octadecenyl]oxy]-1-propanamide chloride (DOTAP chloride) which possess the transfection properties and can find application in medicine and pharmaceutics for intracellular transportation of pharmaceutically active compounds. The invention also refers to a pharmaceutical composition and the use of enantiomerically pure (2S)- or (2R)-DOTAP chloride as an ingredient for preparing drugs.
EFFECT: preparing the compounds which possess the transfection properties and can find application in medicine and pharmaceutics for intracellular transportation of pharmaceutically active compounds.
7 cl, 2 tbl, 6 dwg, 6 ex
Title | Year | Author | Number |
---|---|---|---|
SUSTAINABLE CRYSTALLINE MODIFICATIONS OF CHLORIDE DOTAP | 2012 |
|
RU2627354C2 |
ACTIVE ENANTIOMER OF DODECYL 2-(N,N-DIMETHYLAMINO)-PROPIONATE | 2011 |
|
RU2679308C2 |
METHOD FORASYMMETRICTRANSFORMATION OF SUBSTITUTED 2H-CHROMENE-3-CARBOXY ACIDS DUE TO DIFFERENTIAL SOLUBILITY | 2020 |
|
RU2792894C2 |
COMPOUNDS OF SIMPLE AMINO-CYCLOHEXYLE ETHER AND METHODS OF THEIR USE | 2003 |
|
RU2330017C2 |
METHODS OF PRODUCING AMINOCYCLOHEXYL ETHER COMPOUNDS AND INTERMEDIATE COMPOUNDS, AND METHODS FOR PRODUCTION THEREOF | 2008 |
|
RU2478617C2 |
METHOD OF NEBIVOLOL RACEMATE OBTAINMENT | 2006 |
|
RU2392277C2 |
METHOD OF RACEMIZATION OF OPTICALLY PURE OR ENRICHED PIPERAZIN-2-TERT-BUTYLCARBOXAMIDE SUBSTRATE AND RACEMIC 2-TERT-BUTYLCARBOXAMIDE-4-(3-PICOLYL)PIPERAZINE | 1995 |
|
RU2135482C1 |
METHOD OF PRODUCING SUBSTITUTED 3-ARYLBUTYLAMINE COMPOUNDS | 2004 |
|
RU2380355C2 |
STEREOISOMERS OF ITRACONAZOLE AND SUPERCONAZOLE, METHOD OF THEIR SYNTHESIS, THEIR COMPLEXES AND PHARMACEUTICAL COMPOSITION BASED ON IT | 1993 |
|
RU2127733C1 |
METHOD FOR PREPARING ENANTIOMERICALLY ENRICHED TETRAHYDROBENZOTHIEPINE OXIDES | 1998 |
|
RU2236406C2 |
Authors
Dates
2012-10-10—Published
2005-11-07—Filed